Nucleic Acid Based Gene Therapy Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Nucleic Acid Based Gene Therapy Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The nucleic acid based gene therapy market size has grown strongly in recent years. It will grow from $0.75 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing understanding of human genetics, growing demand for personalized medicine, expanding pipeline of gene therapy products, growing government support for gene therapy, genetic disorders, cancer therapy.

The nucleic acid based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.2 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to expanding indications, increased funding, patient advocacy and awareness, growing investment in gene therapy research and development, expanding scope of gene therapy applications, rare diseases. Major trends in the forecast period include ex vivo gene editing, advances in in vivo gene editing, combination therapies, targeted delivery systems, gene editing for rare diseases, non-viral vectors.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=2820&type=smp

Market Segmentation:
The main technologies in nucleic acid-based gene therapy are anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogues, ribozymes, aptamers, and others. The nucleoside analogues are a significant class of antiviral agents that are generally utilized in the therapy of human immunodeficiency virus (HIV) infection, hepatitis B virus (HBV), hepatitis C virus (HCV), and cytomegalovirus (CMV). The various applications include oncology, muscular dystrophy, muscular disorders, and rare diseases that are used by end-users such as hospitals and clinics and academic and research institutes.

Major Driver - Government And Industry Backing Fueling The Surge In Nucleic Acid-Based Gene Therapy Demand
Rising financial support by the government and the companies is projected to drive the demand for nucleic acid-based gene therapy. Nucleic acid therapeutics are analogs of naturally occurring acids or proteins responsible for genetic expression. The traditional therapies do not have any cure for the treatment of diseases such as cystic fibrosis, hemophilia, sickle cell anemia, thalassemia, and diabetes. Genetic profiling and molecular target identification form the backbone of these classes of drugs. Nucleic acid medication has greater potential for the treatment of these diseases, as they target the genetic basis of diseases and have a permanent cure. Rising financial support by the government and the companies dealing in the market for gene therapy is expected to contribute to increasing the demand for nucleic acid-based gene therapy market. For instance, in August 2022, National Institute of Health (NIH) announced investment of $34 million annually for upcoming 5 years to develop HIV treatment research. The government support for gene therapies will contribute to the growth of the nucleic acid based gene therapy market.

Competitive Landscape:
Major companies operating in the nucleic acid based gene therapy market include Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics plc, Precision BioSciences Inc., REGENXBIO Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Top Trend - Innovative Drug Development Pioneering Advancements In The Nucleic Acid Drugs Market
Major companies operating in the nucleic acid drugs market are developing innovative drugs such as Casimersen to drive revenues in the market. Casimersen is an ASO indicated for the treatment of DMD in patients with a confirmed mutation amenable to exon 45 skipping. For instance, in February 2021, Sarepta Therapeutics Inc., a US-based biotechnology company launched Casimersen (Amondys 45) approved by the Food and Drug Administration, a US-based government agency. This indication is based on a statistically significant increase in dystrophin production in skeletal muscle observed in patients treated with AMONDYS 45, and predicted a clinical benefit for those patients who are exon 45 amenable.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Nucleic Acid Based Gene Therapy Market Characteristics
3. Nucleic Acid Based Gene Therapy Market Trends And Strategies
4. Nucleic Acid Based Gene Therapy Market - Macro Economic Scenario
5. Nucleic Acid Based Gene Therapy Market Size And Growth
…..
27. Nucleic Acid Based Gene Therapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.